AR213831A1 - Procedimiento para la preparacion de 11-desoxi-16-aril-omega-tetranorprostaglandina - Google Patents

Procedimiento para la preparacion de 11-desoxi-16-aril-omega-tetranorprostaglandina

Info

Publication number
AR213831A1
AR213831A1 AR265178A AR26517876A AR213831A1 AR 213831 A1 AR213831 A1 AR 213831A1 AR 265178 A AR265178 A AR 265178A AR 26517876 A AR26517876 A AR 26517876A AR 213831 A1 AR213831 A1 AR 213831A1
Authority
AR
Argentina
Prior art keywords
tetranorprostaglandin
deoxi
aril
omega
procedure
Prior art date
Application number
AR265178A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR213831A1 publication Critical patent/AR213831A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
AR265178A 1975-10-21 1976-10-21 Procedimiento para la preparacion de 11-desoxi-16-aril-omega-tetranorprostaglandina AR213831A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/624,486 US3984400A (en) 1975-10-21 1975-10-21 11-Desoxy-16-aryl-ω-tetranorprostaglandins

Publications (1)

Publication Number Publication Date
AR213831A1 true AR213831A1 (es) 1979-03-30

Family

ID=24502191

Family Applications (1)

Application Number Title Priority Date Filing Date
AR265178A AR213831A1 (es) 1975-10-21 1976-10-21 Procedimiento para la preparacion de 11-desoxi-16-aril-omega-tetranorprostaglandina

Country Status (30)

Country Link
US (1) US3984400A (es)
JP (2) JPS5251353A (es)
AR (1) AR213831A1 (es)
AT (1) AT360673B (es)
BE (1) BE847447A (es)
BG (1) BG31070A3 (es)
CA (1) CA1092103A (es)
CH (1) CH619930A5 (es)
CS (2) CS191343B2 (es)
DD (1) DD128590A5 (es)
DE (1) DE2646878A1 (es)
DK (1) DK472976A (es)
ES (1) ES452538A1 (es)
FI (1) FI762990A (es)
GB (1) GB1520958A (es)
GR (1) GR63621B (es)
HU (1) HU175022B (es)
IE (1) IE44016B1 (es)
IL (1) IL50657A (es)
LU (1) LU76045A1 (es)
NL (1) NL163780C (es)
NO (1) NO763451L (es)
NZ (1) NZ182297A (es)
PH (1) PH11472A (es)
PL (1) PL112539B1 (es)
PT (1) PT65727B (es)
RO (1) RO71900A (es)
SE (1) SE7610995L (es)
SU (2) SU727139A3 (es)
ZA (1) ZA766204B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4365077A (en) * 1975-06-23 1982-12-21 Pfizer Inc. 11-Desoxy-16-aryloxy-ω-tetranorprostaglandins
ZA77160B (en) * 1976-02-13 1977-11-30 Upjohn Co Prostaglandin analogs
US4058564A (en) * 1976-07-26 1977-11-15 The Upjohn Company Aliphatic 2-decarboxy-2-hydroxymethyl-13,14-didehydro-PG compounds
US4140721A (en) * 1976-07-26 1979-02-20 The Upjohn Company 2-Decarboxy-2-hydroxymethyl-13,14-didehydro-17-phenyl-PGA, PGD and PGE compounds
US4177346A (en) * 1976-08-06 1979-12-04 Pfizer Inc. 1,5-Disubstituted-2-pyrrolidones
JPS6210843Y2 (es) * 1981-01-23 1987-03-14
JPS59190734U (ja) * 1983-06-06 1984-12-18 庄田商事株式会社 薄板用連続送り装置
US4576962A (en) * 1983-10-19 1986-03-18 The Procter & Gamble Company Prostaglandin analogues
US4883614A (en) * 1984-07-27 1989-11-28 Hoffman-La Roche Inc. Phenyl substituted-2,4,6,8-nonatetraenoic acid
US4780251A (en) * 1984-07-27 1988-10-25 Hoffman-La Roche Inc. Phenyl substituted-2,4,6,8-nonatetraenoic acid
EP2741738A1 (en) 2011-08-12 2014-06-18 Ascendis Pharma A/S Sustained release composition of prostacyclin
US10544915B2 (en) * 2017-04-27 2020-01-28 Valeo North America, Inc. Vehicle lamp assembly having an improved heat sink with light shield

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3840573A (en) * 1970-12-21 1974-10-08 Searle & Co 2-(3-hydroxy-3-optionally alkylated-1-alkynyl)-3-hydroxy-5-oxygenated cyclopent-1-enealkanoic acids,optical isomers thereof and esters corresponding
US3932389A (en) * 1974-12-11 1976-01-13 Pfizer Inc. 2-Descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-.omega.-pentanorprostaglandins

Also Published As

Publication number Publication date
SU900806A3 (ru) 1982-01-23
IL50657A0 (en) 1976-12-31
CS191321B2 (en) 1979-06-29
LU76045A1 (es) 1977-05-31
ATA785876A (de) 1980-06-15
NL7611660A (nl) 1977-04-25
DE2646878A1 (de) 1977-05-05
US3984400A (en) 1976-10-05
HU175022B (hu) 1980-04-28
JPS5251353A (en) 1977-04-25
NL163780C (nl) 1980-10-15
JPS5531153B2 (es) 1980-08-15
AU1873776A (en) 1978-02-16
IE44016B1 (en) 1981-07-29
DD128590A5 (de) 1977-11-30
GB1520958A (en) 1978-08-09
NZ182297A (en) 1978-09-25
PT65727A (en) 1976-11-01
CS191343B2 (en) 1979-06-29
ES452538A1 (es) 1977-11-01
PL112539B1 (en) 1980-10-31
AT360673B (de) 1981-01-26
RO71900A (ro) 1981-05-30
PT65727B (en) 1978-04-18
PH11472A (en) 1978-02-01
NL163780B (nl) 1980-05-16
SU727139A3 (ru) 1980-04-05
CA1092103A (en) 1980-12-23
BG31070A3 (en) 1981-10-15
GR63621B (en) 1979-11-27
BE847447A (fr) 1977-04-20
FI762990A (es) 1977-04-22
SE7610995L (sv) 1977-04-22
PL193183A1 (pl) 1978-03-28
CH619930A5 (es) 1980-10-31
DK472976A (da) 1977-04-22
IL50657A (en) 1980-05-30
ZA766204B (en) 1977-09-28
JPS5490168A (en) 1979-07-17
IE44016L (en) 1977-04-21
NO763451L (es) 1977-04-22

Similar Documents

Publication Publication Date Title
AR215930A1 (es) Procedimiento para la preparacion de compuestos 2-fenil-3-benzoil-benzotiofeno
MX4717E (es) Procedimiento para la preparacion de derivados de pirrolidina
AR220512A1 (es) Procedimiento para la preparacion de 3-substituido-5-piridinil-2-(1h)-piridinonas
MX3898E (es) Procedimiento mejorado para la preparacion de triesteres de n-fosfonometilglicina
MX3830E (es) Procedimiento para la preparacion de eteres de oxima
MX3818E (es) Procedimiento para la preparacion de enaminas de compuestos hidroxi-3-cefem
MX4089E (es) Procedimiento mejorado para la preparacion de n-fosfonometilglicina
MX4278E (es) Procedimiento para la preparacion de glicosidos de antraciclina
MX4236E (es) Procedimiento para la preparacion de acidos alcanoicos de heteroarilbenzoxepina
MX4614E (es) Procedimiento mejorado para la preparacion de derivados de pirimidina
MX5119E (es) Procedimiento mejorado para la preparacion de derivados de pirimidona
MX143488A (es) Procedimiento para la preparacion de resorcinas
AR220683A1 (es) Procedimiento para la preparacion de m-fenoxibenzaldehido
MX4067E (es) Procedimiento para la preparacion de esteres de i-tiazolinil o i-tiazinilbencimidazol
AR215875A1 (es) Procedimiento para la prepararacion de meta-fenoxi-benzaldehido
MX144711A (es) Procedimiento para la preparacion de 3-metilpiridina
AR210349A1 (es) Procedimiento para la preparacion de 6-coloro-2(piperacinil)piracina
AR213831A1 (es) Procedimiento para la preparacion de 11-desoxi-16-aril-omega-tetranorprostaglandina
MX3636E (es) Procedimiento para la preparacion de propargil-2-fenilamino-imidazolinas-(2)
MX4133E (es) Procedimiento para la preparacion de n-tetrahidrofurfuril-noroximorfonas diastereoisomeras
MX143639A (es) Procedimiento para la preparacion de compuestos disazoicos tetrarreactivos
DOP1977002589A (es) Procedimiento para la preparacion de nuevas tiazolinas.
AR209498A1 (es) Procedimiento para la preparacion de l-piroglutamil-l-pronilamida
AR208361A1 (es) Procedimiento para la preparacion de derivados l-piroglutamil-l-histidil-3-alquil-prolinamida
MX3580E (es) Procedimiento para la preparacion de benzamidas substituidas